Transarterial Liver-Directed Therapies of Neuroendocrine Hepatic Metastases

Seminars in Oncology

Volumn 37, Issue 2, 2010, Pages 118-126

  Nazario, Javier ^a   Gupta, Sanjay ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; IODINATED POPPYSEED OIL; MITOMYCIN; SOMATOSTATIN DERIVATIVE; YTTRIUM 90;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; HUMAN; LIVER METASTASIS; MORTALITY; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SELECTIVE INTERNAL RADIATION THERAPY; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NEUROENDOCRINE; EMBOLIZATION, THERAPEUTIC; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY; YTTRIUM RADIOISOTOPES;

EID: 77952348748     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.03.004     Document Type: Article

References (62)

1. Modlin I.M., Lye K.D., and Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97 (2003) 934-959
2. Neary P.C., Redmond P.H., Houghton T., Watson G.R., and Bouchier-Hayes D. Carcinoid disease: review of the literature. Dis Colon Rectum 40 (1997) 349-362
3. Chamberlain R.S., Canes D., Brown K.T., et al. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 190 (2000) 432-445
4. Modlin I.M., and Sandor A. An analysis of 8,305 cases of carcinoid tumors. Cancer 79 (1997) 813-829
5. Modlin I.M., Latich I., Kidd M., Zikusoka M., and Eick G. Therapeutic options for gastrointestinal carcinoids. Clin Gastroenterol Hepatol 4 (2006) 526-547
6. O'Toole D., Hentic O., Corcos O., and Ruszniewski P. Chemotherapy for gastro-enteropancreatic endocrine tumours. Neuroendocrinology 80 Suppl 1 (2004) 79-84
7. Engstrom P.F., Lavin P.T., Moertel C.G., Folsch E., and Douglass Jr. H.O. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol 2 (1984) 1255-1259
8. Loftus J.P., and van Heerden J.A. Surgical management of gastrointestinal carcinoid tumors. Adv Surg 28 (1995) 317-336
9. Chen H., Hardacre J.M., Uzar A., Cameron J.L., and Choti M.A. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?. J Am Coll Surg 187 (1998) 88-92
10. Norton J.A. Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. Digestion 55 (1994) 98-103
11. Madoff D.C., Gupta S., Ahrar K., Murthy R., and Yao J.C. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17 (2006) 1235-1249
12. Liu D.M., Kennedy A., Turner D., et al. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease. Am J Clin Oncol 32 (2009) 200-215
13. Gupta S., Yao J.C., Ahrar K., et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 9 (2003) 261-267
14. Venook A. Embolization and chemoembolization therapy for neuroendocrine tumors. Curr Opin Oncol 11 (1999) 38-41
15. Strosberg J.R., Choi J., Cantor A.B., and Kvols L.K. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control 13 (2006) 72-78
16. Vogl T.J., Naguib N.N., Zangos S., Eichler K., Hedayati A., and Nour-Eldin N.E. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol 72 (2009) 517-528
17. Gupta S., Johnson M.M., Murthy R., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104 (2005) 1590-1602
18. Kamat P.P., Gupta S., Ensor J.E., et al. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc Intervent Radiol 31 (2008) 299-307
19. Steward M.J., Warbey V.S., Malhotra A., Caplin M.E., Buscombe J.R., and Yu D. Neuroendocrine tumors: role of interventional radiology in therapy. Radiographics 28 (2008) 1131-1145
20. Ajani J.A., Carrasco C.H., Charnsangavej C., Samaan N.A., Levin B., and Wallace S. Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization. Ann Intern Med 108 (1988) 340-344
21. Carrasco C.H., Chuang V.P., and Wallace S. Apudomas metastatic to the liver: treatment by hepatic artery embolization. Radiology 149 (1983) 79-83
22. Hanssen L.E., Schrumpf E., Jacobsen M.B., et al. Extended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report. Acta Oncol 30 (1991) 523-527
23. Bloomston M., Al-Saif O., Klemanski D., et al. Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned. J Gastrointest Surg 11 (2007) 264-271
24. Brown K.T., Koh B.Y., Brody L.A., et al. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol 10 (1999) 397-403
25. Diamandidou E., Ajani J.A., Yang D.J., et al. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol 170 (1998) 339-344
26. Dominguez S., Denys A., Madeira I., et al. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol 12 (2000) 151-157
27. Drougas J.G., Anthony L.B., Blair T.K., et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 175 (1998) 408-412
28. Eriksson B.K., Larsson E.G., Skogseid B.M., Lofberg A.M., Lorelius L.E., and Oberg K.E. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 83 (1998) 2293-2301
29. Hajarizadeh H., Ivancev K., Mueller C.R., Fletcher W.S., and Woltering E.A. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg 163 (1992) 479-483
30. Ho A.S., Picus J., Darcy M.D., et al. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol 188 (2007) 1201-1207
31. Kress O., Wagner H.J., Wied M., Klose K.J., Arnold R., and Alfke H. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors--a retrospective single-center analysis. Digestion 68 (2003) 94-101
32. Loewe C., Schindl M., Cejna M., Niederle B., Lammer J., and Thurnher S. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol 180 (2003) 1379-1384
33. Mavligit G.M., Pollock R.E., Evans H.L., and Wallace S. Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer 72 (1993) 375-380
34. Moertel C.G., Johnson C.M., McKusick M.A., et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120 (1994) 302-309
35. Osborne D.A., Zervos E.E., Strosberg J., et al. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 13 (2006) 572-581
36. Perry L.J., Stuart K., Stokes K.R., and Clouse M.E. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 116 (1994) 1111-1116
37. Roche A., Girish B.V., de Baere T., et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13 (2003) 136-140
38. Ruszniewski P., Rougier P., Roche A., et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 71 (1993) 2624-2630
39. Ruutiainen A.T., Soulen M.C., Tuite C.M., et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 18 (2007) 847-855
40. Therasse E., Breittmayer F., Roche A., et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 189 (1993) 541-547
41. Varker K.A., Martin E.W., Klemanski D., Palmer B., Shah M.H., and Bloomston M. Repeat transarterial chemoembolization (TACE) for progressive hepatic carcinoid metastases provides results similar to first TACE. J Gastrointest Surg 11 (2007) 1680-1685
42. Wangberg B., Westberg G., Tylen U., et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 20 (1996) 892-899
43. Yao K.A., Talamonti M.S., Nemcek A., et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130 (2001) 677-682
44. Kim Y.H., Ajani J.A., Carrasco C.H., et al. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma. Cancer Invest 17 (1999) 474-478
45. Carrasco C.H., Charnsangavej C., Ajani J., Samaan N.A., Richli W., and Wallace S. The carcinoid syndrome: palliation by hepatic artery embolization. AJR Am J Roentgenol 147 (1986) 149-154
46. Murthy R., Nunez R., Szklaruk J., et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25 Suppl 1 (2005) S41-S55
47. Murthy R., Kamat P., Nunez R., et al. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 19 (2008) 145-151
48. Salem R., and Thurston K.G. Radioembolization with 90 yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17 (2006) 1251-1278
49. 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31 (2008) 271-279
50. 90Y-DOTA-lanreotide as effective palliative therapy. Radiology 237 (2005) 718-726
51. King J., Quinn R., Glenn D.M., et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 113 (2008) 921-929
52. 90Y radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 247 (2008) 1029-1035
53. Kalinowski M., Dressler M., Konig A., et al. Selective internal radiotherapy with yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study. Digestion 79 (2009) 137-142
54. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20 (1993) 716-731
55. Krenning E.P., Teunissen J.J., Valkema R., deHerder W.W., deJong M., and Kwekkeboom D.J. Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors. J Endocrinol Invest 28 (2005) 146-150
56. Limouris G.S., Chatziioannou A., Kontogeorgakos D., et al. Selective hepatic arterial infusion of In-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases. Eur J Nucl Med Mol Imaging 35 (2008) 1827-1837
57. Ensminger W.D. Intrahepatic arterial infusion of chemotherapy: pharmacologic principles. Semin Oncol 29 (2002) 119-125
58. Takeuchi I., Ishida H., Suzuki T., Nakada H., Tada M., and Idezuki Y. A case of liver metastases of rectal carcinoid successfully treated with hepatic arterial infusion of methotrexate and 5-fluorouracil. Gan To Kagaku Ryoho 26 (1999) 1929-1932
59. Wadamori K., Oka M., Shimizu R., et al. A case of multiple liver metastasis from ileac carcinoid effectively treated with continuous intraarterial infusion of somatostatin analog. Gan To Kagaku Ryoho 22 (1995) 1669-1672
60. Christante D., Pommier S., Givi B., and Pommier R. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Surgery 144 (2008) 885-893
61. Ruszniewski P., Rougier P., Roche A., et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 71 (1993) 2624-2630
62. Kim Y.H., Ajani J.A., Carrasco C.H., et al. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma. Cancer Invest 17 (1999) 474-478